Anti-Dengue Nanoviricides Achieve Significant Protection In Initial In Vivo Studies On Dengue Hemorrhagic Fever
Links shared publicly online about this topic.
- 1,073total visits
Anti-Dengue Nanoviricides Achieve Significant Protection In Initial In Vivo Studies On Dengue Hemorrhagic Fever
NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company) reports that its anti-Dengue drug candidates demonstrated significant protection in the initial animal survival studies of Dengue virus infect
View full resource at medicalnewstoday.com
Most Recently Shared on June 23, 2010 at 4:14 pm By:
Anti-Dengue Nanoviricides Achieve Significant Protection In Initial In Vivo Studies On Dengue Hemorrhagic Fever: N... http://mnt.to/f/3Fdz
Also Shared By:
Advertisement
MNT Infect Diseases
@mnt_diseases
Anti-Dengue Nanoviricides Achieve Significant Protection In Initial In Vivo Studies On Dengue Hemorrhagic Fever http://mnt.to/3Fdz
1 year ago...